Andy Sassine Icad Inc (ICAD) insider trading activity

ICAD Quotes by TradingView

Andy Sassine is Director of ICAD INC. Currently has a direct ownership of 0 shares of ICAD, which is worth approximately $0. The most recent transaction as insider was on Jul 17, 2025, when has been sold 1,198,382 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

ANDY SASSINE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2025
SELL
Sale (or disposition) back to the issuer
-
1,198,382 Reduced 100.0%
0 Common Stock
Feb 08 2022
SELL
Open market or private sale
$54,900 $5.49 p/Share
10,000 Reduced 0.83%
1,198,382 Common Stock
Feb 07 2022
SELL
Open market or private sale
$52,600 $5.26 p/Share
10,000 Reduced 0.82%
1,208,382 Common Stock
Jan 07 2022
SELL
Open market or private sale
$60,700 $6.07 p/Share
10,000 Reduced 0.81%
1,218,382 Common Stock
Jan 06 2022
SELL
Open market or private sale
$62,000 $6.2 p/Share
10,000 Reduced 0.81%
1,228,382 Common Stock
Dec 07 2021
SELL
Open market or private sale
$72,800 $7.28 p/Share
10,000 Reduced 0.8%
1,238,382 Common Stock
Dec 06 2021
SELL
Open market or private sale
$67,100 $6.71 p/Share
10,000 Reduced 0.79%
1,248,382 Common Stock
Nov 09 2021
SELL
Open market or private sale
$103,000 $10.3 p/Share
10,000 Reduced 0.79%
1,258,382 Common Stock
Nov 08 2021
SELL
Open market or private sale
$108,900 $10.89 p/Share
10,000 Reduced 0.78%
1,268,382 Common Stock
Oct 07 2021
SELL
Open market or private sale
$104,200 $10.42 p/Share
10,000 Reduced 0.78%
1,278,382 Common Stock
Oct 06 2021
SELL
Open market or private sale
$105,600 $10.56 p/Share
10,000 Reduced 0.77%
1,288,382 Common Stock
Sep 14 2021
SELL
Open market or private sale
$106,800 $10.68 p/Share
10,000 Reduced 0.76%
1,298,382 Common Stock
Sep 13 2021
SELL
Open market or private sale
$110,900 $11.09 p/Share
10,000 Reduced 0.76%
1,308,382 Common Stock
Feb 15 2021
BUY
Grant, award, or other acquisition
-
3,500 Added 0.26%
1,318,382 Common Stock

Also insider at

ARCT
Arcturus Therapeutics Holdings Inc. Healthcare
Chief Financial Officer
XCUR
EXICURE, INC. Healthcare
Director
AS

Andy Sassine

Director
San Diego, CA

Track Institutional and Insider Activities on ICAD

Follow ICAD INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICAD shares.

Notify only if

Insider Trading

Get notified when an Icad Inc insider buys or sells ICAD shares.

Notify only if

News

Receive news related to ICAD INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ICAD